COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
E-Scape Bio is a clinical-stage biopharmaceutical company developing brain-penetrant small-molecule therapeutics targeting genetically defined neurodegenerative disease drivers, including an oral S1P5 agonist, LRRK2 G2019S inhibitor, and ApoE4 structure corrector.
